22 Oct Mycophenolate mofetil (MMF)-containing products: Risk of pregnancy loss and congenital malformations – Extension of the post‑treatment contraception period from 6 weeks to 6 months for women of childbearing potential
CellCept, Mycocept, Mycophenolate Teva and Mycokem are medicines that contain the active ingredient mycophenolate mofetil (MMF). Roche Products (Pty) Ltd, Sandoz South Africa (Pty) Ltd, Teva Pharmaceuticals (Pty) Ltd, and Ascend Laboratories (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA)...